Indian Pharma Companies
- All
- News
- Videos
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
New Drug-Making Standards For Indian Pharma Firms After Overseas Deaths
Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load.
-
Gujarat High Court Orders Probe Into Bulgarian's Rape Charge Against Pharma Firm Head
The Gujarat High Court on Friday directed the chief judicial magistrate to pass an order of investigation in a complaint of rape and human trafficking made by a Bulgarian national against the CMD of a leading Indian pharmaceutical company.
-
"Chemicals Within Safe Limits": Indian Firm After WHO Flags Syrup In Iraq
An Indian pharmaceutical company, which has come under the World Health Organisation scanner over the levels of two compounds in its cough syrup, claimed today that the chemicals were within permissible limits.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
-
"Blinded In Hate For...": BJP vs Congress Over Syrup Linked Deaths In Uzbekistan
The alleged role of Indian pharma companies in the deaths of children abroad led to a verbal tussle between the BJP and the Congress on Thursday.
-
BCCI Expecting 2 New IPL Franchises To Go For Rs. 7000-10,000 Crore With Adani Group, Aurobindo Pharma, RPSG In Fray: Report
According to a report, the BCCI is also allowing a consortium of up to three companies or individuals to bid for a IPL franchise.
-
Wockhardt To Manufacture, Supply Sputnik Covid Vaccines
Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine
At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally.
-
Human Trials Of Second COVID-19 Vaccine Candidate Begin
Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from Drugs Controller General of India (DCGI) earlier this month.
-
Indian-Origin Drugs Firm Boss Banned For 5 Years For Price-Fixing In UK
An Indian-origin pharmaceutical industry chief has signed undertakings that ban him from holding a director role at any UK company for the next five years, in connection with his role in companies that were allegedly involved in illegal arrangements such as price-fixing of drugs.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
New Drug-Making Standards For Indian Pharma Firms After Overseas Deaths
Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load.
-
Gujarat High Court Orders Probe Into Bulgarian's Rape Charge Against Pharma Firm Head
The Gujarat High Court on Friday directed the chief judicial magistrate to pass an order of investigation in a complaint of rape and human trafficking made by a Bulgarian national against the CMD of a leading Indian pharmaceutical company.
-
"Chemicals Within Safe Limits": Indian Firm After WHO Flags Syrup In Iraq
An Indian pharmaceutical company, which has come under the World Health Organisation scanner over the levels of two compounds in its cough syrup, claimed today that the chemicals were within permissible limits.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
-
"Blinded In Hate For...": BJP vs Congress Over Syrup Linked Deaths In Uzbekistan
The alleged role of Indian pharma companies in the deaths of children abroad led to a verbal tussle between the BJP and the Congress on Thursday.
-
BCCI Expecting 2 New IPL Franchises To Go For Rs. 7000-10,000 Crore With Adani Group, Aurobindo Pharma, RPSG In Fray: Report
According to a report, the BCCI is also allowing a consortium of up to three companies or individuals to bid for a IPL franchise.
-
Wockhardt To Manufacture, Supply Sputnik Covid Vaccines
Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine
At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally.
-
Human Trials Of Second COVID-19 Vaccine Candidate Begin
Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from Drugs Controller General of India (DCGI) earlier this month.
-
Indian-Origin Drugs Firm Boss Banned For 5 Years For Price-Fixing In UK
An Indian-origin pharmaceutical industry chief has signed undertakings that ban him from holding a director role at any UK company for the next five years, in connection with his role in companies that were allegedly involved in illegal arrangements such as price-fixing of drugs.
